Study to Compare Kowa OCT Bi-μ and the Optovue iVue 100

NACompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

April 21, 2018

Primary Completion Date

September 1, 2018

Study Completion Date

September 1, 2018

Conditions
GlaucomaRetinal DiseaseHealthy
Interventions
DEVICE

KOWA OCT Bi-µ

Non-contact, ultra-high resolution ophthalmic imaging system for fundus imaging and axial cross-sectional and three-dimensional imaging of retinal structures.

DEVICE

Optovue iVue 100

U.S. Food and Drug Administration (FDA) cleared and commercially available Optovue iVue 100

Trial Locations (1)

01810

Andover Eye Associates, Andover

Sponsors
All Listed Sponsors
lead

Kowa Research Institute, Inc.

INDUSTRY